Published in Ann Surg Oncol on June 25, 2009
Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol (2012) 1.15
A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford) (2012) 1.01
Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol (2010) 0.96
Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol (2011) 0.95
Colorectal liver metastases. Int J Surg Oncol (2011) 0.93
Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases. PLoS One (2015) 0.87
Chemotherapy-associated hepatopathy in korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury. Korean J Pathol (2012) 0.86
The association between preoperative chemotherapy and the prevalence of hepatic steatosis in hepatectomy for metastatic colorectal cancer. Arq Bras Cir Dig (2014) 0.84
Risk factors for early recurrence after curative hepatectomy for colorectal liver metastases. Surg Today (2011) 0.84
Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS One (2014) 0.83
Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis. World J Gastroenterol (2015) 0.82
Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis. Int J Clin Exp Pathol (2012) 0.81
Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg (2011) 0.80
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases. World J Gastroenterol (2013) 0.79
Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. World J Gastroenterol (2011) 0.78
Systemic treatment of liver metastases from colorectal cancer. Ther Adv Med Oncol (2013) 0.78
In vivo assessment of intratumoral aspirin injection to treat hepatic tumors. World J Hepatol (2013) 0.78
A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis. Gastrointest Cancer Res (2013) 0.78
External validation of two nomograms for predicting patient survival after hepatic resection for metastatic colorectal cancer. World J Surg (2011) 0.77
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. Langenbecks Arch Surg (2012) 0.77
The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer. J Res Med Sci (2014) 0.77
Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg (2013) 0.77
Diffusion-weighted imaging of the liver: techniques and applications. Magn Reson Imaging Clin N Am (2014) 0.76
Effectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysis. Ecancermedicalscience (2015) 0.76
Designing liver resections and pushing the envelope with resections for hepatic colorectal metastases. Indian J Surg Oncol (2013) 0.75
The role of peri-operative treatment in resectable liver metastases of colorectal cancer. Ther Adv Med Oncol (2010) 0.75
Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities. HPB (Oxford) (2015) 0.75
Perioperative chemotherapy and hepatic resection for resectable colorectal liver metastases. Hepatobiliary Surg Nutr (2015) 0.75
Colorectal cancer. Lancet (2010) 8.36
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol (2009) 7.04
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol (2006) 4.42
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol (2009) 3.69
Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol (2006) 3.46
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg (2006) 3.05
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol (2010) 2.66
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer (2006) 2.51
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. J Natl Cancer Inst (2012) 2.49
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann Surg (2012) 2.43
Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol (2005) 2.38
Colorectal metastasis (liver and lung). Surg Clin North Am (2002) 2.09
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol (2005) 1.52
Urgent need for a new staging system in advanced colorectal cancer. J Clin Oncol (2008) 1.39
The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg (2008) 1.39
Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol (2008) 1.20
Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery. Ann Surg (2010) 1.12
Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. Surgery (2009) 1.10
Lethal fecaloma. J Am Geriatr Soc (2007) 1.09
Cutaneous perianal recurrence on the site of Lone Star Retractor after J-pouch coloanal anastomosis for rectal cancer: report of two cases. Dis Colon Rectum (2008) 1.08
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2012) 1.07
Liver metastases from colorectal cancer: the turning point. J Clin Oncol (2002) 1.04
Surgery of liver metastases from colorectal cancer: new promises. Br Med Bull (2002) 0.93
Hepatectomy for resectable colorectal cancer metastases--indicators of prognosis, definition of resectability, techniques and outcomes. Surg Oncol Clin N Am (2007) 0.88
Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome. Int J Cancer (2011) 0.88
A common hepatic artery passing in front of the portal vein. Surg Radiol Anat (2005) 0.88
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group. J Clin Oncol (2005) 0.87
Metastatic colorectal cancer outcome and fatty liver disease. Nat Rev Gastroenterol Hepatol (2013) 0.87
Accuracy of magnetic resonance imaging in rectal cancer depends on location of the tumor. Dis Colon Rectum (2005) 0.87
Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases. Ann Surg Oncol (2009) 0.86
Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol (2006) 0.84
Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor. Diagn Pathol (2012) 0.84
[Ovarian adenocarcinoma, primary or metastasic tumour of an adenocarcinoma of the colon: the role of molecular biology]. Gastroenterol Clin Biol (2004) 0.83
Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients. Surgery (2006) 0.82
Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases. Surgery (2013) 0.81
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks. BMC Cancer (2007) 0.81
Surgery for colon and rectal cancer. Best Pract Res Clin Gastroenterol (2002) 0.80
Preservation of an intra-pancreatic hepatic artery during duodenopancreatectomy for melanoma metastasis. Surg Radiol Anat (2011) 0.80
Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials. J Surg Oncol (2010) 0.79
Sequenced chemotherapy and surgery for potentially resectable colorectal liver metastases: a debate over goals of research and an approach while the jury remains out. Ann Surg Oncol (2010) 0.79
Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate. J Exp Clin Cancer Res (2011) 0.79
[Recommendations for the management of GIST patients]. Bull Cancer (2005) 0.79
Surgical strategies to synchronous colorectal liver metastases. Dig Dis (2012) 0.78
Anatomical basis for clamping of the right hepatic vein outside the liver during right hepatectomy. Surg Radiol Anat (2006) 0.77
Anatomical bases of prolonged ilio-inguinal-hypogastric regional anesthesia. Surg Radiol Anat (2006) 0.76
A model of primary culture of colorectal cancer and liver metastasis to predict chemosensitivity. J Surg Res (2009) 0.76
Reply to letter: "Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)". Ann Surg (2015) 0.75
[Pleomorphic carcinoma of the large intestine]. Ann Pathol (2003) 0.75
How to manage splenic rupture during major liver resection? Gastroenterol Clin Biol (2006) 0.75
Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases. Scand J Gastroenterol (2011) 0.75
Prognostic factor of recurrence for resected digestive endocrine tumors. Hepatogastroenterology (2009) 0.75
Chemotherapy as initial treatment of locally advanced unresectable pancreatic cancer: a valid option? Gastroenterol Clin Biol (2007) 0.75
[News in the management of the hepatic metastases of colorectal cancer]. Presse Med (2004) 0.75
[Not Available]. Bull Acad Natl Med (2016) 0.75
[Tumors of the esophagus]. Rev Prat (2002) 0.75
Can we predict complete or major response after chemoradiotherapy for rectal cancer by noninvasive methods? Results of a prospective study on 61 patients. Am Surg (2014) 0.75
Can the left hepatic vein always be safely selectively clamped during hepatectomy? The contribution of anatomy. Surg Radiol Anat (2009) 0.75
H-pouch: new isoperistaltic colonic pouch for coloanal anastomosis after rectal resection for cancer: a pilot study. Dis Colon Rectum (2004) 0.75